These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12395996)

  • 41. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
    Meyer UA
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.
    Röhss K; Lind T; Wilder-Smith C
    Eur J Clin Pharmacol; 2004 Oct; 60(8):531-9. PubMed ID: 15349707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gastroesophageal reflux and obstructive sleep apnea syndrome].
    Esteller E; Modolell I; Segarra F; Matiño E; Enrique A; Ademà JM; Estivill E
    Acta Otorrinolaringol Esp; 2005 Nov; 56(9):411-5. PubMed ID: 16353787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
    Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
    van Hout BA; Klok RM; Brouwers JR; Postma MJ
    Clin Ther; 2003 Feb; 25(2):635-46. PubMed ID: 12749518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro-oesophageal reflux disease.
    Simon B; Müller P; Pascu O; Gatz G; Sander P; Huber R; Mascher H
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):791-9. PubMed ID: 12811310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe esophagitis healed in less than a week with intravenous pantoprazole.
    Dabney-Smith K; Nam J; Ghazale A; Cai Q
    J Clin Gastroenterol; 2003 Jan; 36(1):78-9. PubMed ID: 12488715
    [No Abstract]   [Full Text] [Related]  

  • 48. Pantoprazole, a new proton-pump inhibitor, has a precise and predictable profile of activity.
    Parsons ME
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S15-20. PubMed ID: 8930575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.
    Gillessen A; Beil W; Modlin IM; Gatz G; Hole U
    J Clin Gastroenterol; 2004 Apr; 38(4):332-40. PubMed ID: 15087692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recurrent anaphylaxis linked to pantoprazole.
    Kollmeier AP; Eddleston J; Zuraw BL; Christiansen SC
    J Allergy Clin Immunol; 2004 Oct; 114(4):975-7. PubMed ID: 15480345
    [No Abstract]   [Full Text] [Related]  

  • 51. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
    Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.
    Van Rensburg CJ; Honiball PJ; Van Zyl JH; Grundling HD; Eloff FP; Spies SK; Simjee AE; Theron I; Fischer R; Louw JA
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1023-8. PubMed ID: 10468676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
    Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.
    Corinaldesi R; Valentini M; Belaïche J; Colin R; Geldof H; Maier C
    Aliment Pharmacol Ther; 1995 Dec; 9(6):667-71. PubMed ID: 8824655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy of pantoprazole compared with ranitidine.
    Bader JP; Delchier JC
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():47-52. PubMed ID: 8180294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
    Armbrecht U; Abucar A; Hameeteman W; Schneider A; Stockbrügger RW
    Aliment Pharmacol Ther; 1997 Oct; 11(5):959-65. PubMed ID: 9354207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
    Escourrou J; Deprez P; Saggioro A; Geldof H; Fischer R; Maier C
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1481-91. PubMed ID: 10571605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.
    Scholten T; Dekkers CP; Schütze K; Körner T; Bohuschke M; Gatz G
    Digestion; 2005; 72(2-3):76-85. PubMed ID: 16113546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily.
    Bardhan KD; Dillon J; Axon AT; Cooper BT; Tildesley G; Wyatt JI; Gatz G; Braun W
    Aliment Pharmacol Ther; 2000 Jan; 14(1):59-67. PubMed ID: 10632646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.